⚕ GalenOps CRO console
← SITE012 (BRA)

SITE012-0266

completed
Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer Phase III · Site: SITE012 (BRA) (Dr. Kowalski) · consented 2023-01-03
Adverse events
10
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-02-09 (study day 19); relationship: N

mild assessed 2026-08-18

Grade 1 Hypothyroidism — outcome: RECOVERED/RESOLVED; onset 2023-05-15 (study day 114); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-06-29 (study day 159); relationship: Y

moderate assessed 2026-08-18

Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-07-22 (study day 182); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2023-08-13 (study day 204); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-10-18 (study day 270); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-12-12 (study day 325); relationship: not assessed

severe assessed 2026-08-18

Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-12-15 (study day 328); relationship: N

moderate assessed 2026-08-18

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2024-02-03 (study day 378); relationship: not assessed

severe assessed 2026-08-18

Grade 3 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2024-07-13 (study day 539); relationship: N

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.